Importance of treatment institution in head and neck cancer radiotherapy

Otolaryngology - Head and Neck Surgery

Volumn 141, Issue 2, 2009, Pages 172-176

  Kubicek, Gregory J ^a   Wang, Fen ^b   Reddy, Eashwar ^b   Shnayder, Yelizaveta ^b   Cabrera, Cristina E ^b   Girod, Douglas A ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; EARLY CANCER; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HOSPITALS, PUBLIC; HUMANS; KANSAS; MALE; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 67651030398     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2009.03.019     Document Type: Article

References (20)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 58 (2008) 71-96
2. Rosenthal D.I., and Ang K.K. Altered radiation therapy fractionation chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma. Semin Radiat Oncol 14 (2004) 153-166
3. Schrag D., Earle C., Xu F., et al. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J Natl Cancer Inst 98 (2006) 163-171
4. Meyerhardt J.A., Catalano P.J., Schrag D., et al. Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence. Ann Intern Med 139 (2003) 649-657
5. Gouma D.J., van Geenen R.C., van Gulik T.M., et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg 232 (2000) 786-795
6. Xirasagar S., Lien Y.C., Lin H.C., et al. Procedure volume of gastric cancer resections versus 5-year survival. Eur J Surg Oncol 34 (2008) 23-29
7. Verhoef C., van de Weyer R., Schaapveld M., et al. Better survival in patients with esophageal cancer after surgical treatment in university hospitals: a plea for performance by surgical oncologists. Ann Surg Oncol 14 (2007) 1678-1687
8. Gillis C.R., and Hole D.J. Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland. Br Med J 312 (1996) 145-148
9. Cheung M.C., Hamilton K., Sherman R., et al. Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: an examination of 13,469 surgical patients. Ann Surg Oncol 16 (2009) 3-13
10. Kuo E.Y., Chang Y., and Wright C.D. Impact of hospital volume on clinical and economic outcomes for esophagectomy. Ann Thorac Surg 72 (2001) 1118-1124
11. Gutierrez J.C., Perez E.A., Moffat F.L., et al. Should soft tissue sarcomas be treated at high-volume centers?. An analysis of 4205 patients. Ann Surg 245 (2007) 952-958
12. Collette L., Sylvester R.J., Stenning S.P., et al. Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. J Natl Cancer Inst 91 (1999) 839-846
13. Rischin D., Peters L., O'Sullivan B., et al. Phase III study of tirapazamine, cisplatin and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 26 suppl 15S (2008) LBA6008
14. Benasso M., Lionetto R., Corvò R., et al. Impact of the treating institution on the survival of patients with head and neck cancer treated with concomitant alternating chemotherapy and radiation. Eur J Cancer 39 (2003) 1895-1898
15. Fu K.K., Pajak Tj., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyper-fractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 90-03. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
16. Kam M.K., Leung S.F., Zee B., et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early stage nasopharyngeal carcinoma patients. J Clin Oncol 25 (2007) 4873-4879
17. Pow E.H., Kwong D.L., McMillian A.S., et al. Xerostomia and quality of life after intensity modultated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66 (2006) 981-991
18. Chao K.S., Low D.A., Perez C.A., et al. Intensity-modulated radiation therapy in head and neck cancers: the Mallinckrodt experience. Int J Cancer 90 (2000) 92-103
19. Garden A.S., Morrison W., Rosenthal D., et al. Intensity modulated radiation therapy (IMRT) for metastatic cervical adenopathy from oropharynx carcinoma. Int J Radiat Oncol Biol Phys 60 (2004) S318
20. Huang K., Lee N., and Xia P. Intensity-modulated radiotherapy in the treatment of oropharyngeal carcinoma: a single institutional experience. Int J Radiat Oncol Biol Phys 57 (2003) S302